Story thread · 2 reports / 2 sources
Electra amasses $350M in biotech’s latest big IPO
biopharmadive.com · 16h · first report
How the coverage leans
Across 2 sources · syndicated copies counted once
Nearly a dozen biotechnology firms have matched or raised more than $300 million in their initial public offerings in 2026, a figure not seen since new stock sales peaked in 2021, according to BioPharma Dive data.
The coverage
- Antibody therapy developer Electra upsizes IPO seeking nearly $350M
seekingalpha.com · 2h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.